1 |
Haidar YM, Cosman BC. Obesity epidemiology. Clin Colon Rectal Surg. 2011 ; 24(4) : 205-10.
DOI
|
2 |
Jeong JW, Cho SW. Trend research of the human body-oriented obesity studies on Korean Medicine. J Korean Med Rehab. 2016 ; 26(1) : 49-61.
DOI
|
3 |
Hwang MJ, Shin HD, Song MY. Literature review of herbal medicines on treatment of obesity since 2000-mainly about Ephedra Herba. J Soc Korean Med Obes Res. 2007 ; 7(1) : 39-54.
|
4 |
Lee JM. Longevity and life preservation in Eastern medicine, Seoul : Haklimsa. 1986 : 333-8.
|
5 |
Lim SY, Park SW, Joo JH, Kim SR, Kim DJ, Choi WS. The effects of Taeeumjowui-tang (Taiyintiaowei-tang) on obesity in Sasang constitution. J East-West Med. 2012 ; 37(4) : 109-16.
|
6 |
Park KM, Song YK, Lim HH. Review on the research relative to taeeumjowui-Tang (Taiyintiaowei-tang). J Soc Korean Med Obes Res. 2009 ; 9(1) : 23-6.
|
7 |
Lee JE, Song YK, Lim HH. Clinical trial of Taeeumjowui-tang (Taiyintiaowei-tang) on obese patients: randomized, double blind, placebo-controlled study. J Orient Rehab Med. 2010 ; 20(4) : 197-213.
|
8 |
Park SJ, Nahmkoong W, Cheon CH, Park JS, Jang BH, Shin YC, et al. Efficacy and safety of Taeeumjowi-tang in obese Korean adults: a double-blind, randomized, and placebo-controlled pilot trial. Evid-Based Complement Altern Med. 2013 ; 2013 : 498935.
|
9 |
Hansen D, Astrup A, Toubro S, Finer N, Kopelman P, Hilsted J, et al. Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity-results from the European multi-centre STORM trial. Int J Obes Relat Metab Disord. 2001 ; 25(4) : 496-501.
DOI
|
10 |
Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2014: Korea National Health and Nutrition Examination Survey (KNHANES VI-2). Sejong, Cheongju : Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. 2014.
|
11 |
Heo YS, Park JM, Kim YJ, Kim SM, Park DJ, Lee SK, et al. Bariatric surgery versus conventional therapy in obese Korea patients: a multicenter retrospective cohort study. J Korean Surg Soc. 2012 ; 83(6) : 335-42.
DOI
|
12 |
Fabricatroe AN. Predictors of attrition and weight loss success: results from a randomized controlled trial. Behav Res Ther. 2009 ; 47(8) : 685-91.
DOI
|
13 |
Wright SM, Aronne LJ. Causes of obesity. Abdom Imaging. 2012 ; 37(5) : 730-2.
DOI
|
14 |
Kim SY, Park YJ, Park YB. Review on predictors of dropout and weight loss maintenance in weight loss interventions. J Korean Med. 2016 ; 39(3) : 62-73.
|
15 |
Park CY, Kim YS, Ryu MS, Nam SY, Park HS, Kim SM. A phase 3 double-blind, parallel-group, placebo-controlled trail of the efficacy and safety of sibutramine (Reductil) in the treatment of obese patients. Korean J Obes. 2001 ; 10(4) : 336-47.
|
16 |
Dhurandhar NA, Blank RC, Schumacher D, Atkinson RL. Initial weight loss as a predictor of response to obesity drugs. Int J Obes Relat Metab Disord. 1999 ; 23(12) : 1333-6.
DOI
|
17 |
Handjieva-Darlenska T, Handjiev S, Larsen TM, van Baak MA, Jebb S, Papadaki A, et al. Initial weight loss on an 800-kcal diet as a predictor of weight loss success after 8 weeks: the Diogenes study. Eur J Clin Nutr. 2010 ; 64(9) : 994-9.
DOI
|
18 |
Park HS, Kim KS, Kim BT, Lee KW, Ahn CW, Choi WH. Double-blind, randomized, multi-center, comparative clinical trial of Sibutramine Mesilate with Sibutramine hydrochloride for evaluating efficacy and safety in obese patients. Korean J Obes. 2008 ; 17(2) : 82-90.
|
19 |
Spitzer RL, Kroenke K, Williams JBW. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999 ; 282(18) : 1737-44.
DOI
|
20 |
Lim KH, Park YN, Kim DH, Shin IH, Lee WS, Kim JB. A preliminary study of the standardization of the Korean version of Patient Health Questionnaire-9. Korean J Helath Promot Dis Prev. 2009 ; 9(4) : 275-81.
|
21 |
Department of Biofunctional Medicine&Dianostics in Colleges of Korean Medicine. Biofunctional medicine. Paju : Koonja. 2008 : 81-101.
|
22 |
Sartorio A, Maffiuletti NA, Agosti F, Lafortuna CL, Genderrelated changes in body composition, muscle strength and power output after a short-term multidisciplinary weight loss intervention in morbid obesity. J Endocrinol Invest. 2005 ; 28(6) : 494-501.
DOI
|
23 |
Coughlin JW, Smith MT. Sleep, obesity, and weight loss in adults: is there a rationale for providing sleep interventions in the treatment of obesity? Int Rev Psychiatry. 2014 ; 26(2) : 177-88.
DOI
|
24 |
Goode RW, Ye L, Sereika SM, Zheng Y, Mattos M, Acharya SD, et al. Socio-demographic, anthropometric and psychosocial predictors of attrition across behavioral weight loss trials. Sour Doc Eat Behav. 2016 ; 20 : 27-33.
DOI
|
25 |
Jung HH, Choi YS, Kim SH, Sohn KJ, Kim DG, Hong JI, et al. Association between metabolic syndrome and heart rate variability. Korean J Obes. 2005 ; 14(4) : 220-7.
|
26 |
Moroshko I, Brennan L, O'Brien P. Predictor of dropout in weight loss interventions a systematic review of the literature. Obes Rev. 2011 ; 12(11) : 912-34.
DOI
|
27 |
Kase CA, Piers AD, Schuamberg K, Forman EM, Butryn ML. The relationship of alcohol use to weight loss in the context of behavioral weight loss treatment. Appetite. 2016 ; 99 : 105-11.
DOI
|
28 |
Alizai PH, Akkerman MK, Kaemmer D, Ulmer F, Klink CD, Ernst S, et al. Presurgical assessment of bariatric patients with the Patient Health Questionnaire (PHQ)-A screening of the prevalence of psychosocial comorbidity. Health Qual Life Outcome. 2015 ; 13(1) : 80-6.
DOI
|
29 |
Latner JD, Ciao AC. Weight-loss history as a predictor of obesity treatment outcome: prospective, long-term results from behavioral, group self-help treatment. J Health Psychology. 2014 ; 19(2) : 253-61.
DOI
|
30 |
Ludman E, Simon G, Ichikawa L, Operskalski B, Arteburn D, Linde J, et al. Does depression reduce the effectiveness of behavioral weight loss treatment? Behav Med. 2009 ; 35(4) : 126-34.
DOI
|
31 |
Yackobovitch-Gavan M, Steinberg DM, Endevelt R, Benyamini Y. Factors associated with dropout in a group weight-loss programme: a longitudinal investigation. J Hum Nutr Diet. 2015 ; 28(2) : 33-40.
DOI
|